The Global Market for Blood Pressure Monitoring and Measurement Instruments is Forecast to Reach US$3.0 Billion by 2022

Alarming Rise in Global Prevalence of Hypertension and the Need for Timely Monitoring Drive Demand for Blood Pressure Monitoring Instruments, According to a New Report by Global Industry Analysts, Inc.

                                                                                                

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Blood Pressure Monitoring and Measurement Instruments market. The global market for Blood Pressure Monitoring and Measurement Instruments is forecast to reach US$3.0 billion by 2022, driven by the growing incidence of high blood pressure and the urgent need for timely monitoring for preventing its life threatening complications.

Hypertension is one of the major non-communicable and chronic diseases and a leading cause of disability and death worldwide. The disease remains undetected and untreated in majority of the patients due to lack of apparent symptoms until it leads to life threatening consequences. Regular measurement of blood pressure becomes vital because untreated hypertension is one of the potential causes for peripheral vascular disease, retinal hemorrhage, renal impairment, visual impairment and various heart related disorders. According to WHO, the disease is the cause of about 20% male deaths in the world and about 24% female deaths and accounts for more than 60% of strokes and more than 45% of coronary heart diseases each year. In addition to increase in incidence and prevalence of hypertension, factors such as growing patient awareness, improving ease-of-use and accuracy of devices, encouraging reimbursement policies and development of non-invasive techniques to simplify regular BP monitoring constitute the primary growth drivers for the global BP monitoring and measurement market. Lack of a definitive cure for hypertension and availability of BP monitoring and measurement devices at nominal prices represent other important growth drivers.

Future growth in the market will be driven by the sheer number of undiagnosed cases of hypertension, which reflects huge market growth potential for BP monitoring and measurement devices. Development of innovative and affordable products, and the evolution of BP measurement devices based on wearable technologies represent another factor benefiting market expansion in the coming years. Uncomfortable and bulky cuffs which strangled arms while taking readings are being increasingly replaced by devices which can be comfortably worn. Wearable, cuffless, and connected devices hold the potential for enabling continuous, beat-to-beat blood pressure monitoring in real-time, thus improving remote monitoring of hypertensive and cerebral/cardiovascular patients, even during their sleep. The devices instantly sync with customized applications via wireless networks, Wi-Fi and Bluetooth and allow constant monitoring as well as sharing of information pertaining to heart rate and blood pressure with caregivers and doctors. Steady launch of smart connected devices that are extremely accurate in readings and are equipped with inbuilt reminder systems are also poised to benefit market adoption in the near term.

As stated by the new market research report on Blood Pressure Monitoring and Measurement Instruments, the United States represents the largest market worldwide. Asia-Pacific ranks as the fastest growing market with a CAGR of 9.3% over the analysis period, led by the huge tapped potential present in poorly penetrated markets with inadequate monitoring practices in the management of established hypertension and high burden of undiagnosed hypertension; rise in risk factors such as globalization of unhealthy lifestyles, urbanization induced behavioral and dietary changes with serious implications for health and well-being; growing awareness and increase in patient involvement in treatment plans and the resulting rise of self-monitoring as a standard practice.

Key players covered in the report include A&D Medical, American Diagnostic Corporation, Beurer GmbH, Bokang Instruments Co., Ltd., Briggs Healthcare, Draegerwerk AG & Co., KGaA, GE Healthcare Ltd., GF Health Products Inc., HealthSTATS International Pte Ltd., iHealth Labs, Inc., Jitron Pte Ltd., Medel International srl, Microlife AG, Omron Healthcare Co., Ltd., Philips Healthcare, Rossmax International Ltd., Shenzhen Kingyield Technology Co., Ltd., Spacelabs Healthcare Inc., SunTech Medical Inc., W. A. Baum Co. Inc., Welch Allyn Inc., and Withings, among others.

The research report titled “Blood Pressure Monitoring and Measurement Instruments: A Global Strategic Business Report” announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, mergers, acquisitions and other strategic industry activities. The report also provides market estimates and projections in US$ for all major geographic markets including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Australia, Hong Kong, Indonesia, Korea, Malaysia, New Zealand, Philippines, Singapore, Taiwan, and Thailand), the Middle East & Africa, and Latin America. Product segments analyzed in the report include Sphygmomanometers (Aneroid Sphygmomanometers and Digital Sphygmomanometers), Ambulatory and Automated BP Monitors, and Blood Pressure Transducers.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.